Kaplan Brett
Insider CIK 1778763 · PRVL Chief Financial Officer · NONE Director · ELYM Chief Operating Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CLYM Climb Bio, Inc. | A Award deriv | 2025-01-13 | 2025-01-15 | 500,000 | — | $0 | 500,000 | SEC↗ |
| ELYM Eliem Therapeutics, Inc. | A Award deriv | 2024-08-26 | 2024-08-26 | 77,500 | — | $0 | 77,500 | SEC↗ |
| ELYM Eliem Therapeutics, Inc. | A Award deriv | 2024-08-26 | 2024-08-26 | 465,000 | — | $0 | 465,000 | SEC↗ |
| CMPX Compass Therapeutics, Inc. | A Award deriv | 2022-02-18 | 2022-02-23 | 30,000 | — | $0 | 30,000 | SEC↗ |
| PRVL Prevail Therapeutics Inc. | D To issuer deriv | 2021-01-22 | 2021-01-26 | 95,000 | — | $0 | 0 | SEC↗ |
| PRVL Prevail Therapeutics Inc. | D To issuer deriv | 2021-01-22 | 2021-01-26 | 64,565 | — | $0 | 0 | SEC↗ |
| PRVL Prevail Therapeutics Inc. | D To issuer deriv | 2021-01-22 | 2021-01-26 | 347,004 | — | $0 | 0 | SEC↗ |
| NONE Compass Therapeutics, Inc. | A Award deriv | 2020-09-10 | 2020-09-14 | 60,000 | — | $0 | 60,000 | SEC↗ |
| PRVL Prevail Therapeutics Inc. | A Award deriv | 2020-02-19 | 2020-03-11 | 95,000 | — | $0 | 95,000 | SEC↗ |